| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
20 |
| issn |
1791-3004
1791-2997 |
| issueIdentifier |
1 |
| pageRange |
15-20 |
| publicationName |
Molecular Medicine Reports |
| startingPage |
15 |
| bibliographicCitation |
Zhu B. Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review). Mol Med Report. 2008 Jan 01;(). doi: 10.3892/mmr.1.1.15. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa9ab86ba588625526a3e102416d6294 |
| date |
2008-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/21479371
https://doi.org/10.3892/mmr.1.1.15 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36486
https://portal.issn.org/resource/ISSN/1791-3004
https://portal.issn.org/resource/ISSN/1791-2997 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review) |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3001028
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_70b5e487895f71f891c796aca5947a19
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2276200fc93f3050bf367a43673f00a7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26e3b3a0ea8ee6116067a3b73abe7e5c
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219296 |